nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—NR3C1—endogenous depression	0.566	0.597	CbGaD
Mifepristone—CYP2D6—endogenous depression	0.383	0.403	CbGaD
Mifepristone—CYP3A7—endocrine gland—endogenous depression	0.0013	0.0373	CbGeAlD
Mifepristone—PGR—cardiovascular system—endogenous depression	0.00114	0.0329	CbGeAlD
Mifepristone—AR—forebrain—endogenous depression	0.00108	0.031	CbGeAlD
Mifepristone—PGR—pituitary gland—endogenous depression	0.00101	0.0292	CbGeAlD
Mifepristone—AR—adrenal cortex—endogenous depression	0.000998	0.0288	CbGeAlD
Mifepristone—ABCC1—adrenal cortex—endogenous depression	0.000948	0.0273	CbGeAlD
Mifepristone—AR—cardiovascular system—endogenous depression	0.00091	0.0262	CbGeAlD
Mifepristone—PGR—adrenal gland—endogenous depression	0.000904	0.0261	CbGeAlD
Mifepristone—PGR—thyroid gland—endogenous depression	0.000872	0.0251	CbGeAlD
Mifepristone—NR3C1—brainstem—endogenous depression	0.000808	0.0233	CbGeAlD
Mifepristone—AR—pituitary gland—endogenous depression	0.000806	0.0232	CbGeAlD
Mifepristone—PGR—endocrine gland—endogenous depression	0.000784	0.0226	CbGeAlD
Mifepristone—NR3C1—forebrain—endogenous depression	0.00078	0.0225	CbGeAlD
Mifepristone—ABCC1—pituitary gland—endogenous depression	0.000766	0.0221	CbGeAlD
Mifepristone—PGR—nervous system—endogenous depression	0.000734	0.0211	CbGeAlD
Mifepristone—NR3C1—adrenal cortex—endogenous depression	0.000723	0.0208	CbGeAlD
Mifepristone—AR—adrenal gland—endogenous depression	0.00072	0.0208	CbGeAlD
Mifepristone—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.000714	0.0436	CbGpPWpGaD
Mifepristone—PGR—central nervous system—endogenous depression	0.000706	0.0204	CbGeAlD
Mifepristone—AR—thyroid gland—endogenous depression	0.000695	0.02	CbGeAlD
Mifepristone—PGR—cerebellum—endogenous depression	0.00069	0.0199	CbGeAlD
Mifepristone—ABCB1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.000685	0.0418	CbGpPWpGaD
Mifepristone—ABCC1—adrenal gland—endogenous depression	0.000684	0.0197	CbGeAlD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—FKBP5—endogenous depression	0.000669	0.0409	CbGpPWpGaD
Mifepristone—ABCC1—thyroid gland—endogenous depression	0.00066	0.019	CbGeAlD
Mifepristone—NR3C1—cardiovascular system—endogenous depression	0.000659	0.019	CbGeAlD
Mifepristone—AR—endocrine gland—endogenous depression	0.000624	0.018	CbGeAlD
Mifepristone—CYP3A7—Xenobiotics—CYP2D6—endogenous depression	0.000603	0.0368	CbGpPWpGaD
Mifepristone—CYP2D6—brainstem—endogenous depression	0.000601	0.0173	CbGeAlD
Mifepristone—AR—nervous system—endogenous depression	0.000584	0.0168	CbGeAlD
Mifepristone—NR3C1—pituitary gland—endogenous depression	0.000584	0.0168	CbGeAlD
Mifepristone—CYP2D6—forebrain—endogenous depression	0.00058	0.0167	CbGeAlD
Mifepristone—AR—central nervous system—endogenous depression	0.000563	0.0162	CbGeAlD
Mifepristone—PGR—brain—endogenous depression	0.000561	0.0162	CbGeAlD
Mifepristone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—endogenous depression	0.000559	0.0341	CbGpPWpGaD
Mifepristone—ABCC1—cerebellum—endogenous depression	0.000522	0.0151	CbGeAlD
Mifepristone—NR3C1—adrenal gland—endogenous depression	0.000522	0.015	CbGeAlD
Mifepristone—NR3C1—midbrain—endogenous depression	0.000515	0.0148	CbGeAlD
Mifepristone—NR3C1—thyroid gland—endogenous depression	0.000503	0.0145	CbGeAlD
Mifepristone—CYP3A5—endocrine gland—endogenous depression	0.000456	0.0131	CbGeAlD
Mifepristone—NR3C1—endocrine gland—endogenous depression	0.000452	0.013	CbGeAlD
Mifepristone—AR—brain—endogenous depression	0.000447	0.0129	CbGeAlD
Mifepristone—CYP3A5—Xenobiotics—CYP2D6—endogenous depression	0.000436	0.0266	CbGpPWpGaD
Mifepristone—ABCC1—brain—endogenous depression	0.000424	0.0122	CbGeAlD
Mifepristone—NR3C1—nervous system—endogenous depression	0.000423	0.0122	CbGeAlD
Mifepristone—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.000422	0.0258	CbGpPWpGaD
Mifepristone—CYP3A5—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000419	0.0256	CbGpPWpGaD
Mifepristone—ABCB1—forebrain—endogenous depression	0.000417	0.012	CbGeAlD
Mifepristone—NR3C1—central nervous system—endogenous depression	0.000408	0.0117	CbGeAlD
Mifepristone—PGR—Nuclear Receptors—NR3C1—endogenous depression	0.000407	0.0248	CbGpPWpGaD
Mifepristone—NR3C1—cerebellum—endogenous depression	0.000398	0.0115	CbGeAlD
Mifepristone—ABCB1—adrenal cortex—endogenous depression	0.000387	0.0111	CbGeAlD
Mifepristone—ABCB1—cardiovascular system—endogenous depression	0.000353	0.0102	CbGeAlD
Mifepristone—CYP3A4—endocrine gland—endogenous depression	0.000342	0.00986	CbGeAlD
Mifepristone—CYP2D6—endocrine gland—endogenous depression	0.000337	0.0097	CbGeAlD
Mifepristone—NR3C1—brain—endogenous depression	0.000324	0.00933	CbGeAlD
Mifepristone—PGR—Nuclear Receptor transcription pathway—NR3C1—endogenous depression	0.000321	0.0196	CbGpPWpGaD
Mifepristone—CYP3A4—nervous system—endogenous depression	0.00032	0.00923	CbGeAlD
Mifepristone—CYP2D6—nervous system—endogenous depression	0.000315	0.00908	CbGeAlD
Mifepristone—ABCB1—pituitary gland—endogenous depression	0.000313	0.00901	CbGeAlD
Mifepristone—AR—Nuclear Receptors—NR3C1—endogenous depression	0.00031	0.0189	CbGpPWpGaD
Mifepristone—CYP3A4—central nervous system—endogenous depression	0.000308	0.00888	CbGeAlD
Mifepristone—CYP2D6—central nervous system—endogenous depression	0.000303	0.00874	CbGeAlD
Mifepristone—CYP2D6—cerebellum—endogenous depression	0.000296	0.00854	CbGeAlD
Mifepristone—ABCB1—adrenal gland—endogenous depression	0.000279	0.00805	CbGeAlD
Mifepristone—ABCB1—midbrain—endogenous depression	0.000276	0.00794	CbGeAlD
Mifepristone—ABCB1—thyroid gland—endogenous depression	0.000269	0.00777	CbGeAlD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—GATA3—endogenous depression	0.000264	0.0161	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000258	0.0157	CbGpPWpGaD
Mifepristone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00025	0.0153	CbGpPWpGaD
Mifepristone—CYP3A7—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000247	0.0151	CbGpPWpGaD
Mifepristone—AR—Nuclear Receptor transcription pathway—NR3C1—endogenous depression	0.000245	0.0149	CbGpPWpGaD
Mifepristone—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.000242	0.0148	CbGpPWpGaD
Mifepristone—ABCB1—endocrine gland—endogenous depression	0.000242	0.00698	CbGeAlD
Mifepristone—CYP2D6—brain—endogenous depression	0.000241	0.00694	CbGeAlD
Mifepristone—AR—Regulation of Androgen receptor activity—NR3C1—endogenous depression	0.000237	0.0145	CbGpPWpGaD
Mifepristone—ABCB1—nervous system—endogenous depression	0.000227	0.00653	CbGeAlD
Mifepristone—ABCB1—central nervous system—endogenous depression	0.000218	0.00629	CbGeAlD
Mifepristone—ABCB1—cerebellum—endogenous depression	0.000213	0.00615	CbGeAlD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000203	0.0124	CbGpPWpGaD
Mifepristone—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.000203	0.0124	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—endogenous depression	0.0002	0.0122	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—GATA3—endogenous depression	0.000198	0.0121	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000195	0.0119	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000195	0.0119	CbGpPWpGaD
Mifepristone—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000195	0.0119	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—endogenous depression	0.000183	0.0112	CbGpPWpGaD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000181	0.0111	CbGpPWpGaD
Mifepristone—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000179	0.0109	CbGpPWpGaD
Mifepristone—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000173	0.0106	CbGpPWpGaD
Mifepristone—ABCB1—brain—endogenous depression	0.000173	0.00499	CbGeAlD
Mifepristone—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.000172	0.0105	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—endogenous depression	0.000169	0.0103	CbGpPWpGaD
Mifepristone—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.000167	0.0102	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.000162	0.00992	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000162	0.00986	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000156	0.00953	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000156	0.00953	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL10—endogenous depression	0.000156	0.00951	CbGpPWpGaD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000153	0.00933	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000148	0.00904	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000147	0.00896	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—endogenous depression	0.000139	0.00846	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—GATA3—endogenous depression	0.000137	0.00836	CbGpPWpGaD
Mifepristone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000123	0.00749	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000123	0.00748	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000118	0.00723	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000118	0.00723	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000117	0.00717	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000113	0.00692	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00011	0.00674	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000108	0.0066	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—CYP2D6—endogenous depression	0.000108	0.00658	CbGpPWpGaD
Mifepristone—CYP3A7—Metapathway biotransformation—CYP2D6—endogenous depression	0.000106	0.00649	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.0001	0.00611	CbGpPWpGaD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—endogenous depression	9.95e-05	0.00607	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—POMC—endogenous depression	9.7e-05	0.00592	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	9.64e-05	0.00588	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—HTR2A—endogenous depression	9.57e-05	0.00584	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—MAOA—endogenous depression	8.91e-05	0.00544	CbGpPWpGaD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	8.87e-05	0.00541	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—BDNF—endogenous depression	8.6e-05	0.00525	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	8.42e-05	0.00514	CbGpPWpGaD
Mifepristone—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	8.31e-05	0.00507	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL10—endogenous depression	8.21e-05	0.00501	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—COMT—endogenous depression	8.17e-05	0.00499	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—MAOA—endogenous depression	8.12e-05	0.00495	CbGpPWpGaD
Mifepristone—CYP3A7—Metapathway biotransformation—COMT—endogenous depression	8.06e-05	0.00492	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	7.85e-05	0.00479	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—CYP2D6—endogenous depression	7.8e-05	0.00476	CbGpPWpGaD
Mifepristone—CYP3A5—Metapathway biotransformation—CYP2D6—endogenous depression	7.69e-05	0.00469	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL10—endogenous depression	7.6e-05	0.00464	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—HTR2A—endogenous depression	7.26e-05	0.00443	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—endogenous depression	7.19e-05	0.00439	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	6.82e-05	0.00416	CbGpPWpGaD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	6.31e-05	0.00385	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—COMT—endogenous depression	5.91e-05	0.00361	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—MAOA—endogenous depression	5.87e-05	0.00358	CbGpPWpGaD
Mifepristone—CYP3A5—Metapathway biotransformation—COMT—endogenous depression	5.83e-05	0.00356	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—NR3C1—endogenous depression	5.55e-05	0.00339	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—POMC—endogenous depression	5.28e-05	0.00323	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	5.13e-05	0.00313	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	5.11e-05	0.00312	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NR3C1—endogenous depression	4.23e-05	0.00258	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—COMT—endogenous depression	4.2e-05	0.00256	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—MAOA—endogenous depression	4.17e-05	0.00255	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	4.14e-05	0.00253	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	4.12e-05	0.00252	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	3.93e-05	0.0024	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—POMC—endogenous depression	3.82e-05	0.00233	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—WASF2—endogenous depression	3.8e-05	0.00232	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—WASF1—endogenous depression	3.65e-05	0.00222	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	3.62e-05	0.00221	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	3.57e-05	0.00218	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TPH1—endogenous depression	3.49e-05	0.00213	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ADM—endogenous depression	3.48e-05	0.00212	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	3.34e-05	0.00204	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TPH1—endogenous depression	3.04e-05	0.00186	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CRH—endogenous depression	2.91e-05	0.00178	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—OXT—endogenous depression	2.91e-05	0.00178	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HTR1A—endogenous depression	2.81e-05	0.00171	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—COMT—endogenous depression	2.75e-05	0.00168	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—MAOA—endogenous depression	2.73e-05	0.00166	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—POMC—endogenous depression	2.72e-05	0.00166	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	2.71e-05	0.00165	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HTR2C—endogenous depression	2.71e-05	0.00165	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NR3C1—endogenous depression	2.67e-05	0.00163	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TPH2—endogenous depression	2.65e-05	0.00161	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CACNB2—endogenous depression	2.65e-05	0.00161	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—DPYD—endogenous depression	2.6e-05	0.00159	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CACNA1C—endogenous depression	2.42e-05	0.00148	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HTR7—endogenous depression	2.37e-05	0.00145	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.33e-05	0.00142	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TPH2—endogenous depression	2.31e-05	0.00141	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CACNB2—endogenous depression	2.31e-05	0.00141	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—DPYD—endogenous depression	2.27e-05	0.00139	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TPH1—endogenous depression	2.2e-05	0.00134	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP2D6—endogenous depression	2.11e-05	0.00129	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CACNA1C—endogenous depression	2.11e-05	0.00129	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NR3C1—endogenous depression	2.04e-05	0.00124	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP2D6—endogenous depression	1.84e-05	0.00113	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—POMC—endogenous depression	1.78e-05	0.00108	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TPH2—endogenous depression	1.67e-05	0.00102	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CACNB2—endogenous depression	1.67e-05	0.00102	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HTR2A—endogenous depression	1.66e-05	0.00101	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TPH1—endogenous depression	1.66e-05	0.00101	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—DPYD—endogenous depression	1.64e-05	0.001	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—COMT—endogenous depression	1.6e-05	0.000978	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MAOA—endogenous depression	1.59e-05	0.000971	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TPH1—endogenous depression	1.56e-05	0.000955	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CACNA1C—endogenous depression	1.53e-05	0.000931	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—COMT—endogenous depression	1.4e-05	0.000853	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MAOA—endogenous depression	1.39e-05	0.000847	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2D6—endogenous depression	1.33e-05	0.000814	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—POMC—endogenous depression	1.33e-05	0.00081	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CACNB2—endogenous depression	1.26e-05	0.000768	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TPH2—endogenous depression	1.26e-05	0.000768	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—DPYD—endogenous depression	1.24e-05	0.000756	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CACNB2—endogenous depression	1.19e-05	0.000724	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TPH2—endogenous depression	1.19e-05	0.000724	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—DPYD—endogenous depression	1.17e-05	0.000712	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CACNA1C—endogenous depression	1.15e-05	0.000703	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CACNA1C—endogenous depression	1.08e-05	0.000662	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—POMC—endogenous depression	1.04e-05	0.000632	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TPH1—endogenous depression	1.02e-05	0.000624	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—COMT—endogenous depression	1.01e-05	0.000617	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2D6—endogenous depression	1.01e-05	0.000614	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MAOA—endogenous depression	1e-05	0.000612	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—POMC—endogenous depression	9.04e-06	0.000552	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CACNB2—endogenous depression	7.75e-06	0.000473	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TPH2—endogenous depression	7.75e-06	0.000473	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—DPYD—endogenous depression	7.63e-06	0.000466	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—COMT—endogenous depression	7.62e-06	0.000465	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MAOA—endogenous depression	7.57e-06	0.000462	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—COMT—endogenous depression	7.18e-06	0.000439	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MAOA—endogenous depression	7.13e-06	0.000435	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CACNA1C—endogenous depression	7.09e-06	0.000433	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—POMC—endogenous depression	6.53e-06	0.000399	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2D6—endogenous depression	6.2e-06	0.000378	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—POMC—endogenous depression	4.93e-06	0.000301	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—COMT—endogenous depression	4.7e-06	0.000287	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MAOA—endogenous depression	4.66e-06	0.000285	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—POMC—endogenous depression	4.64e-06	0.000284	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—POMC—endogenous depression	3.04e-06	0.000185	CbGpPWpGaD
